CTC Clinical Trial Consultants AB
- Address
- lock Available on a paid plan
Male Urogenital Diseases
Research at CTC Clinical Trial Consultants AB is centered on developing innovative therapies for male urogenital diseases, particularly erectile dysfunction.
- Safety assessment of new biologic agents
- Pharmacokinetic profiling of subcutaneous formulations
- Exploration of combination therapies for urogenital conditions
The study contributes to expanding therapeutic choices for men with erectile dysfunction, aligning with CTC's commitment to advancing urogenital care.
Nutritional and Metabolic Diseases
The metabolic program at the site targets overweight and obesity, aiming to evaluate novel anti‑obesity therapy that supports weight management and metabolic health.
- Safety and tolerability of emerging anti‑obesity compounds
- Pharmacodynamic evaluation of metabolic regulators
- Assessment of co‑administration strategies for weight loss
These trials seek to broaden treatment options for individuals struggling with obesity, reinforcing CTC’s focus on metabolic disease research.
Respiratory Tract Diseases
In the respiratory division, CTC investigates therapies for idiopathic pulmonary fibrosis, a progressive condition within respiratory tract diseases.
- Safety monitoring of investigational inhaled agents
- Pharmacokinetic studies in pulmonary disease
- Exploration of disease‑modifying potential in fibrotic lungs
The research aims to improve outcomes for patients with fibrotic lung disease, reflecting the site’s dedication to advancing respiratory health.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1AstraZeneca AB1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in CTC Clinical Trial Consultants AB
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of AZD9550 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Overweight and Obese Patients with Non-alcoholic Steatohepatitis | AstraZeneca AB | Phase I | Not Yet Recruiting | Sep 2023 | — |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ascorbic Acid | 1 | Unknown | 2023-09-28 | 2023-09-28 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.